"SILHOUETTE MID FACE SUTURES ARE FDA 510(k)

cleared for market" 

 

Silhouette Mid-face Suture™ Receives TGA Approval in Australia

For Immediate Release: May 7, 2007 (Corona), California – Kolster Methods, Inc., the inventor and developer of the semi-bioabsorbable Silhouette Mid-face Suture™ for the fixation of soft tissue in the aesthetic and plastic and reconstructive surgery markets, announced today that it has received Australian TGA approval for the  Silhouette Mid-face Suture™device. The Silhouette Mid-face Suture™device received FDA clearance in October 2006, CE Marking in January of 2007, and is pending approval in Korea and a host of other countries. The device will be exclusively distributed in Australia by Austramedex. Austramedex is the leading Australian company for the marketing and distribution of many aesthetic surgery products.

This product is the very first in a series of Silhouette suture products with various “indications for use” that we plan to introduce over the next twelve months that will enable us to continue to meet the needs of our surgeon customers in the plastic surgery market. Current trials are underway that are designed to determine the use and effectiveness of the device in the brow, breast and abdomen of patients and also separate studies are being conducted for wound closure applications.

About Kolster Methods, Inc. (K.M.I.)
Kolster Methods, Inc., develops, manufactures and markets a range of aesthetic and plastic and reconstructive surgery products for liposuction, endoscopic and laparoscopic surgery. Located in Corona, California, Kolster Methods Inc. is a privately held company.

For more information contact K.M.I. at 951-737-5476.

Silhouette Sutures • Aesthetic Surgery • Endoscopic Surgery • Laparoscopic Surgery

 

© 2012 Innovative Med Inc.   All rights reserved.

Terms of Use and Privacy Policy

Revised: Thursday, January 19, 2012 08:10:53 AM.

 

Web Design by MarCia Sauser of Gal Graphic Inc- Web Master Christina Nichols of Gal Tec Inc